|
Volumn 28, Issue 2, 1996, Pages 685-686
|
Prolongation of xenograft survival by soluble complement receptor type 1 and antithrombin-III combination therapy
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTITHROMBIN III;
COMPLEMENT COMPONENT C1;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
BLOOD CLOTTING;
CELL STIMULATION;
COMPLEMENT ACTIVATION;
COMPLEMENT INHIBITION;
CONFERENCE PAPER;
CONTROLLED STUDY;
ENDOTHELIUM CELL;
GRAFT REJECTION;
GRAFT SURVIVAL;
HISTOLOGY;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
THROMBOCYTE ACTIVATION;
XENOTRANSPLANTATION;
ANIMALS;
ANTITHROMBIN III;
DRUG THERAPY, COMBINATION;
GRAFT SURVIVAL;
GUINEA PIGS;
HEART TRANSPLANTATION;
IMMUNOSUPPRESSION;
MALE;
PROSTAGLANDINS;
RATS;
RATS, INBRED STRAINS;
RECEPTORS, COMPLEMENT;
TIME FACTORS;
TRANSPLANTATION, HETEROLOGOUS;
|
EID: 0029869203
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (3)
|
References (0)
|